Dr. Avery Nicole Nelson, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 580 Court St, North Building, Level 1a, Keene, NH 03431 Phone: 603-354-5496 Fax: 603-354-5498 |
Paul D Righi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Cheshire Medical Center-dartmouth Hitchcock - Keene, Keene, NH 03431 Phone: 603-354-5454 |
Dr. Donald V. Wilson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: Dartmouth Hitchcock Clinic/keene, 590 Court St, Keene, NH 03431 Phone: 603-354-5454 |
News Archive
Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced preliminary results from a Phase 1b study to assess the safety, tolerability and pharmacodynamic (PD) activity of ACE-031 following multiple ascending doses in healthy postmenopausal volunteers.
MedeAnalytics, a leading provider of healthcare performance management solutions, today released an estimate of the impact on Medicare payments to hospitals by recently enacted debt-ceiling legislation. Bottom line: over the next 10 years, individual hospitals could see Medicare payments reduced by $1.1 to $1.4 million per year.
The practice of indirect referrals by nonpublic emergency departments and their affiliated physicians are prevalent in communities with a public hospital option.
Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.
› Verified 2 days ago